Emmessar Biotech & Nutrition Limited has intimated the Bombay Stock Exchange about an upcoming Board of Directors meeting. The meeting is scheduled to be held on Friday, August 7, 2026, in Mumbai.
The primary agenda of the board meeting is to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2026 (Q1 FY27).
Additionally, the company has confirmed that the trading window for dealing in equity shares of the company remains closed until August 9, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The trading window closure was previously communicated to the exchange via letter dated June 26, 2026.
The document was digitally signed by Priyanka Omprakash Sharma, Company Secretary, on August 1, 2026, at 15:45:29 IST.